The Growing Evidence for Psilocybin-Facilitated Smoking Cessation
Comments from Matthew Johnson of Johns Hopkins provide an update on this research.
Articles - Page 20
LSD and Psilocybin May Alleviate Cluster Headaches
Three clinical trials are underway to find out if these psychedelic compounds can provide relief for patients.
Get to Know the Beta Carbolines – Newcomers to the Science of Magic Mushrooms
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
Study Finds Aeruginascin Metabolite 4-HO-TMT is Active at the Serotonin 5-HT2A Receptor
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
Using Zebrafish as an Experimental Model in Psychedelic Research
These creatures have more in common with humans than one might suspect.
The Biosynthesis of DMT
Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.
Psilocybin to Treat Anxiety and Depression in Cancer Patients
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
Beyond Ayahuasca: Therapeutic Effects of N,N-Dimethyltryptamine (DMT)
Researchers are uncovering reasons to think there’s more to DMT than just hallucinations.
What is Allosteric Modulation?
This phenomenon plays an important role in psychedelic drug research and development.